Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 17, 2018

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Malignant Neoplasms of Lip Oral Cavity and PharynxOropharyngeal Cancer
Interventions
PROCEDURE

Modified Barium Swallow (MBS)

Modified barium swallow (MBS) performed at baseline and at 6 months, 2 years, and 5 years after finishing radiation therapy.

BEHAVIORAL

Swallowing Questionnaire

Swallowing questionnaire completed at baseline, every week while receiving radiation therapy, and at 6 months, 2 years, and 5 years after finishing radiation therapy.

BEHAVIORAL

Symptom Questionnaire

Symptom questionnaire completed at baseline, every week while receiving radiation therapy, and at 6 months, 2 years, and 5 years after finishing radiation therapy.

PROCEDURE

Video-Strobe Procedure

Video-strobe procedure to check vocal cords performed at baseline, at week 3 during radiation therapy, and at 6 months, 2 years, and 5 years after finishing radiation therapy.

PROCEDURE

MRI Guided Intensity Modulated Radiotherapy (IMRT) Planning

IMRT planned with MRI guidance.

PROCEDURE

Standard-of-Care Intensity Modulated Radiotherapy (IMRT) Planning

IMRT planned by standard-of-care.

RADIATION

Intensity Modulated Radiotherapy (IMRT)

Participants receive an individualized prescription of up to 70 Gy in 33 fractions with radiation therapy (RT) given once daily, 5 days a week, over 6 weeks and 3 days.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER